In our study we demonstrated significant lowering of GLUT4 expression on NK cells in patients with colon cancer not only in group with coexisting type 2 diabetes but also in subjects with normal glucose tolerance. The gene discussed is SLC2A4; the disease is malignant colon neoplasm.